»» Searching for " UNTK "
 Related Search Tags:  SURG RPRX UNTK Nasdaq:SURG Nasdaq:RPRX Nasdaq:UNTK
Showing Results 1-1 of 1 |  Sort by:     
Page 1 of 1  |  Go to page   
Welcome to CRWENewswire, Stocks to Watch for Tuesday December 13th, 2011. I am Shalika Jayasekera. On its first quarter fiscal 2012 results, Synergetics USA Inc - SURG - posted sales of $13.5 million, a 12.0% increase year over year, and net income from continuing operations increased 81.3% to $1.2 million compared to the same period the prior year. Repros Therapeutics Inc - RPRX - provided top line results for the end of dosing analysis on its Phase 2 clinical study of Androxal in hypogonadal men with type 2 diabetes. Trials completed by the company have shown that unlike testosterone replacement therapy, Androxal stimulates normal production of the male hormone by the testes. and finally; UniTek Global Services Inc - UNTK - reported that it has been awarded a three-year turf agreement in the Northeast region with a major wireless carrier. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera
(SURG, RPRX, UNTK)...
Categories: Videos 
Added: 162 days ago
By: karmastock
Runtime: 1m27s
Views: 35
 | Comments: 0
Not yet rated
Page 1 of 1  |  Go to page   
About Us   |   Terms of Use   |   Privacy Policy   |   Copyright Notes   |   Contact Us   |   Help   |      |   Back to the top of this page
Copyright © 2006-2007 bongoTYube. All rights reserved.    | Page created in 0.0398 seconds.